Purification and characterization of an amyloidogenic repeat domain from the functional amyloid Pmel17.


Journal

Protein expression and purification
ISSN: 1096-0279
Titre abrégé: Protein Expr Purif
Pays: United States
ID NLM: 9101496

Informations de publication

Date de publication:
11 2021
Historique:
received: 21 05 2021
revised: 16 07 2021
accepted: 17 07 2021
pubmed: 23 7 2021
medline: 29 1 2022
entrez: 22 7 2021
Statut: ppublish

Résumé

The pre-melanosomal protein (Pmel17) is a human functional amyloid that supports melanin biosynthesis within melanocytes. This occurs in the melanosome, a membrane-bound organelle with an acidic intraluminal pH. The repeat region of Pmel17 (RPT, residues 315-444) has been previously shown to form amyloid aggregates under acidic melanosomal conditions, but not under neutral cytosolic conditions, when expressed and purified using a C-terminal hexa-histidine tag (RPT-His). Given the importance of protonation states in RPT-His aggregation, we questioned whether the histidine tag influenced the pH-dependent behavior. In this report, we generated a tagless RPT by inserting a tobacco etch virus (TEV) protease recognition sequence (ENLYGQ(G/S)) immediately upstream of a native glycine residue at position 312 in Pmel17. After purification of the fusion construct using a histidine tag, cleavage with TEV protease generated a fully native RPT (nRPT) spanning resides 312-444. We characterized the aggregation of nRPT, which formed amyloid fibrils under acidic conditions (pH ≤ 6) but not at neutral pH. Characterizing the morphologies of nRPT aggregates using transmission electron microscopy revealed a pH-dependent maturation from short, curved structures at pH 4 to paired, rod-like fibrils at pH 6. This was accompanied by a secondary structural transition from mixed random coil/β-sheet at pH 4 to canonical β-sheet at pH 6. We also show that pre-formed nRPT fibrils undergo disaggregation upon dilution into pH 7 buffer. More broadly, this strategy can be utilized to generate native amyloidogenic domains from larger proteins by utilizing intrinsic N-terminal glycine or serine residues.

Identifiants

pubmed: 34293440
pii: S1046-5928(21)00127-3
doi: 10.1016/j.pep.2021.105944
pmc: PMC8403166
mid: NIHMS1727861
pii:
doi:

Substances chimiques

Amyloid 0
Fluorescent Dyes 0
PMEL protein, human 0
Protein Aggregates 0
gp100 Melanoma Antigen 0
Serine 452VLY9402
Histidine 4QD397987E
Endopeptidases EC 3.4.-
TEV protease EC 3.4.-
Glycine TE7660XO1C

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

105944

Subventions

Organisme : Intramural NIH HHS
ID : ZIA HL006034
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

J Mol Biol. 2014 Dec 12;426(24):4074-4086
pubmed: 25451784
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21447-52
pubmed: 21106765
Biochemistry. 2003 Aug 5;42(30):9022-7
pubmed: 12885235
J Biol Chem. 2006 Jul 28;281(30):21198-21208
pubmed: 16682408
J Biol Chem. 2011 Mar 11;286(10):8385-8393
pubmed: 21148556
J Mol Biol. 2020 Nov 20;432(23):6173-6186
pubmed: 33068637
J Cell Biol. 2015 Aug 17;210(4):529-39
pubmed: 26283796
PLoS Biol. 2006 Jan;4(1):e6
pubmed: 16300414
Biomolecules. 2017 Jun 29;7(3):
pubmed: 28661450
Annu Rev Biochem. 2017 Jun 20;86:69-95
pubmed: 28125289
Methods Enzymol. 1999;309:274-84
pubmed: 10507030
J Phys Chem B. 2017 Jan 19;121(2):412-419
pubmed: 28005369
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96
pubmed: 24854788
Isr J Chem. 2017 Jul;57(7-8):613-621
pubmed: 28993712
Biochim Biophys Acta. 2005 Aug 10;1751(2):119-39
pubmed: 16027053
J Mol Biol. 2018 Oct 12;430(20):3696-3706
pubmed: 29886018
J Phys Chem B. 2021 Apr 22;125(15):3781-3789
pubmed: 33835818
J Cell Biol. 2001 Feb 19;152(4):809-24
pubmed: 11266471
Biochemistry. 2011 Dec 13;50(49):10567-9
pubmed: 22092386
Nat Commun. 2021 Mar 12;12(1):1620
pubmed: 33712624
Biochim Biophys Acta Proteins Proteom. 2019 May;1867(5):519-528
pubmed: 30471451
Science. 2009 Jul 17;325(5938):328-32
pubmed: 19541956
Chembiochem. 2014 Jul 21;15(11):1569-72
pubmed: 24954152
Biochim Biophys Acta Proteins Proteom. 2019 Oct;1867(10):961-969
pubmed: 30716507
Trends Biochem Sci. 2007 May;32(5):217-24
pubmed: 17412596
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19726-31
pubmed: 19033461
Chem Commun (Camb). 2018 Jun 21;54(51):6983-6986
pubmed: 29774336
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13731-6
pubmed: 19666488
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22671-22673
pubmed: 32868414
Biophys J. 2011 Nov 2;101(9):2242-50
pubmed: 22067164
Methods Mol Biol. 2017;1586:221-230
pubmed: 28470608
J Biol Chem. 2020 May 22;295(21):7544-7553
pubmed: 32277052

Auteurs

Dexter N Dean (DN)

Laboratory of Protein Conformation and Dynamics, Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, National Institutes of Health, United States.

Jennifer C Lee (JC)

Laboratory of Protein Conformation and Dynamics, Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, National Institutes of Health, United States. Electronic address: leej4@nhlbi.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH